drugset / Trial / NCT00661466
Efficacy and Safety of A Collagen Bupivacaine Implant in Patients After Gastrointestinal Surgery
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether the CollaRx Bupivacaine Implant (bupivacaine sponge) is safe and effective in reducing the amount of narcotic pain medication needed to control pain during the first 24 hours after gastrointestinal (GI) surgery.
Timeline
- Start
- 2008-07-24
- Primary completion
- 2009-01-10
- Completion
- 2009-02-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | — | Other |
Indications
No indication recorded.